118 related articles for article (PubMed ID: 28133064)
1. [Treatment Experience with Sorafenib for Lung Metastases of Hepatocellular Carcinoma Complicated with Interstitial Pneumonia].
Shuto T; Murakami M; Shimizu J; Koga C; Yasuyama A; Matsumura T; Kameda C; Kawabata R; Hirota M; Yoshikawa M; Noura S; Hasegawa J
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1582-1584. PubMed ID: 28133064
[TBL] [Abstract][Full Text] [Related]
2. Sorafenib-associated psoriasiform eruption in a patient with hepatocellular carcinoma.
İlknur T; Akarsu S; Çarsanbali S; Lebe B; Fetil E
J Drugs Dermatol; 2014 Aug; 13(8):899-900. PubMed ID: 25116964
[No Abstract] [Full Text] [Related]
3. Abdominal Distension in a Patient With Hepatocellular Carcinoma. Benign Pneumatosis Intestinalis and Pneumoperitoneum Associated With Sorafenib Therapy.
Huang YH; Siao FY; Yen HH
Gastroenterology; 2015 Aug; 149(2):e12-3. PubMed ID: 26123559
[No Abstract] [Full Text] [Related]
4. Complete pathological response induced by sorafenib for advanced hepatocellular carcinoma with multiple lung metastases and venous tumor thrombosis allowing for curative resection.
Kitajima T; Hatano E; Mitsunori Y; Taura K; Fujimoto Y; Mizumoto M; Okajima H; Kaido T; Minamiguchi S; Uemoto S
Clin J Gastroenterol; 2015 Oct; 8(5):300-5. PubMed ID: 26249525
[TBL] [Abstract][Full Text] [Related]
5. [Metastatic adrenal necrosis under sorafenib treatment for hepatocellular carcinoma].
Fabries P; Pauleau G; Brardjanian S; Artéaga C; Guisset M; Coton T
Presse Med; 2013 Feb; 42(2):235-7. PubMed ID: 22425476
[No Abstract] [Full Text] [Related]
6. Interstitial pneumonia suspected during regorafenib administration and exacerbated by subsequent therapy with lenvatinib for unresectable hepatocellular carcinoma.
Kotani K; Enomoto M; Okada M; Yoshida K; Motoyama H; Fujii H; Hagihara A; Uchida-Kobayashi S; Morikawa H; Murakami Y; Tamori A; Kawada N
Clin J Gastroenterol; 2019 Aug; 12(4):355-360. PubMed ID: 31020569
[TBL] [Abstract][Full Text] [Related]
7. Complete Response to the Combination of Pembrolizumab and Sorafenib for Metastatic Hepatocellular Carcinoma: A Case Report.
Chen SC; Chao Y; Yang MH
Am J Gastroenterol; 2017 Apr; 112(4):659-660. PubMed ID: 28381841
[No Abstract] [Full Text] [Related]
8. A case of reversible cardiomyopathy associated with sorafenib in advanced hepatocellular carcinoma.
Park H; Han SH; Kang H; Park K
Int J Cardiol; 2012 Sep; 160(1):e10-1. PubMed ID: 22289299
[No Abstract] [Full Text] [Related]
9. Pharmacokinetic interaction between sorafenib and prednisolone in a patient with hepatocellular carcinoma.
Noda S; Shioya M; Hira D; Fujiyama Y; Morita SY; Terada T
Cancer Chemother Pharmacol; 2013 Jul; 72(1):269-72. PubMed ID: 23673446
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma treated by sorafenib with complete radiological response according to mRECIST criteria: could we stop the treatment? About four cases.
Poullenot F; Bioulac-Sage P; Laumonier H; Saric J; Carteret T; Blanc JF
Acta Oncol; 2014 Mar; 53(3):420-3. PubMed ID: 23713857
[No Abstract] [Full Text] [Related]
11. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial.
Bruix J; Takayama T; Mazzaferro V; Chau GY; Yang J; Kudo M; Cai J; Poon RT; Han KH; Tak WY; Lee HC; Song T; Roayaie S; Bolondi L; Lee KS; Makuuchi M; Souza F; Berre MA; Meinhardt G; Llovet JM;
Lancet Oncol; 2015 Oct; 16(13):1344-54. PubMed ID: 26361969
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib induced hepatic encephalopathy.
Sidhu SS; Agarwal S; Goyal O; Kishore H; Sidhu S
Acta Gastroenterol Belg; 2017; 80(4):537-538. PubMed ID: 29560652
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib-induced Acute Pancreatitis: A Case Report and Review of the Literature.
Chou JW; Cheng KS; Huang CW
Intern Med; 2016; 55(6):623-7. PubMed ID: 26984079
[TBL] [Abstract][Full Text] [Related]
14. [A case of tuberculosis that occurred during treatment of hepatocellular carcinoma with sorafenib].
Kobayashi Y; Emura M; Nakamura T; Cho T; Seto R; Nomura N; Nomizo T; Igarashi S
Kekkaku; 2013 Sep; 88(9):671-5. PubMed ID: 24298694
[TBL] [Abstract][Full Text] [Related]
15. Fever within 2 Weeks of Sorafenib Therapy Predicts Favorable Treatment Efficacy in Patients with Advanced Hepatocellular Carcinoma.
Kuzuya T; Ishigami M; Ishizu Y; Honda T; Hayashi K; Ishikawa T; Nakano I; Goto H; Hirooka Y
Oncology; 2016; 91(5):261-266. PubMed ID: 27622905
[TBL] [Abstract][Full Text] [Related]
16. Lenvatinib-induced Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma.
Imakura T; Sato S; Tomonari T; Murakami K; Takahashi N; Naito N; Mima M; Kagawa K; Koyama K; Nishimura H; Kawano H; Nokihara H; Azuma M; Takayama T; Nishioka Y
Intern Med; 2022 Apr; 61(8):1211-1217. PubMed ID: 34544944
[TBL] [Abstract][Full Text] [Related]
17. [A Case of Wilson's Disease with Psoriasis Vulgaris, Complicated with Hepatocellular Carcinoma and Successfully Treated with Sorafenib].
Nakagawa T; Chubachi S
Gan To Kagaku Ryoho; 2015 Sep; 42(9):1107-9. PubMed ID: 26469170
[TBL] [Abstract][Full Text] [Related]
18. Interstitial pneumonia induced by combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma.
Yamamoto S; Tomita Y; Hoshida Y; Iizuka N; Marubashi S; Miyamoto A; Nagano H; Dono K; Umeshita K; Nakamori S; Sakon M; Aozasa K; Monden M
J Gastroenterol; 2004 Aug; 39(8):793-7. PubMed ID: 15338375
[TBL] [Abstract][Full Text] [Related]
19. Sorafenib: 10 years after the first pivotal trial.
Gadaleta-Caldarola G; Infusino S; Divella R; Ferraro E; Mazzocca A; De Rose F; Filippelli G; Abbate I; Brandi M
Future Oncol; 2015; 11(13):1863-80. PubMed ID: 26161924
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib as an adjuvant therapy for resectable hepatocellular carcinoma: A single center experience.
Antoniou EA; Margonis GA; Amini N; Anastasiou M; Angelou A; Kim Y; Kouraklis G
J BUON; 2016; 21(5):1189-1194. PubMed ID: 27837622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]